ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Aims to boost speed & precision in patient care
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
The system is powered by BrainSense technology, which has received approval from USFDA
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Subscribe To Our Newsletter & Stay Updated